Immune activation in HIV infection: What can the natural hosts of simian immunodeficiency virus teach us?

Current Opinion in HIV and AIDS

Volumn 11, Issue 2, 2016, Pages 201-208

  Ploquin, Mickaël J ^a   Silvestri, Guido ^b   Müller Trutwin, Michaela ^a  

^a INSTITUT PASTEUR   (France)

^b EMORY UNIVERSITY   (United States)

Author keywords

inflammation; microbial translocation; natural hosts; reservoirs; simian immunodeficiency virus

Indexed keywords

INTERFERON;

CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE COURSE; EFFECTOR CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE ACTIVATION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LYMPHOID ORGAN; MACROPHAGE; MEMORY CELL; MICROBIAL TRANSLOCATION; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; NATURAL HOST; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TH17 CELL; VIRUS CARRIER; VIRUS CELL INTERACTION; VIRUS INDUCTION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE; ANIMAL; BIOLOGICAL MODEL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INFLAMMATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; MODELS, IMMUNOLOGICAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TH17 CELLS;

EID: 84957652377     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000238     Document Type: Review

References (79)

1. Liovat AS, Jacquelin B, Ploquin MJ, et al. African non human primates infected by SIV: why don't they get sick? Lessons from studies on the early phase of nonpathogenic SIV infection. Curr HIV Res 2009; 7: 39-50.
2. Broussard SR, Staprans SI, White R, et al. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J Virol 2001; 75: 2262-2275.
3. Goldstein S, Ourmanov I, Brown CR, et al. Wide range of viral load in healthy African green monkeys naturally infected with simian immunodeficiency virus. J Virol 2000; 74: 11744-11753.
4. Gueye A, Diop OM, Ploquin MJ, et al. Viral load in tissues during the early and chronic phase of non-pathogenic SIVagm infection. J Med Primatol 2004; 33: 83-97.
5. Gordon SN, Dunham RM, Engram JC, et al. Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus: implications for AIDS pathogenesis. J Virol 2008; 82: 3725-3735.
6. Klatt NR, Villinger F, Bostik P, et al. Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys. J Clin Invest 2008; 118: 2039-2049.
7. Pandrea I, Ribeiro RM, Gautam R, et al. Simian immunodeficiency virus SIVagm dynamics in African green monkeys. J Virol 2008; 82: 3713-3724.
8. Pandrea IV, Gautam R, Ribeiro RM, et al. Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J Immunol 2007; 179: 3035-3046.
9. Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010; 6: e1001052.
10. Paiardini M, Muller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev 2013; 254: 78-101.
11. Chakrabarti LA, Lewin SR, Zhang L, et al. Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J Virol 2000; 74: 1209-1223.
12. Kornfeld C, Ploquin MJ, Pandrea I, et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 2005; 115: 1082-1091.
13. Diop OM, Gueye A, Dias-Tavares M, et al. High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J Virol 2000; 74: 7538-7547.
14. Pandrea I, Cornell E, Wilson C, et al. Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates. Blood 2012; 120: 1357-1366.
15. Klatt NR, Chomont N, Douek DC, Deeks SG. Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunol Rev 2013; 254: 326-342.
16. Ploquin MJ, Desoutter JF, Santos PR, et al. Distinct expression profiles of TGF-beta1 signaling mediators in pathogenic SIVmac and nonpathogenic SIVagm infections. Retrovirology 2006; 3: 37.
17. Cecchinato V, Trindade CJ, Laurence A, et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol 2008; 1: 279-288.
18. Favre D, Lederer S, Kanwar B, et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 2009; 5: e1000295.
19. Bosinger SE, Li Q, Gordon SN, et al. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 2009; 119: 3556-3572.
20. Campillo-Gimenez L, Laforge M, Fay M, et al. Nonpathogenesis of simian immunodeficiency virus infection is associated with reduced inflammation and recruitment of plasmacytoid dendritic cells to lymph nodes, not to lack of an interferon type I response, during the acute phase. J Virol 2010; 84: 1838-1846.
21. Diop OM, Ploquin MJ, Mortara L, et al. Plasmacytoid dendritic cell dynamics and alpha interferon production during simian immunodeficiency virus infection with a nonpathogenic outcome. J Virol 2008; 82: 5145-5152.
22. Harris LD, Tabb B, Sodora DL, et al. Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques. J Virol 2010; 84: 7886-7891.
23. Jacquelin B, Mayau V, Targat B, et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009; 119: 3544-3555.
24. Jacquelin B, Petitjean G, Kunkel D, et al. Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferonalpha during primary SIVagm infection. PLoS Pathog 2014; 10: e1004241. The work confirms that the control of immune activation in natural hosts is not a consequence of lower levels of IFN-a production.
25. Bosinger SE, Johnson ZP, Folkner KA, et al. Intact type I interferon production and IRF7 function in sooty mangabeys. PLoS Pathog 2013; 9: e1003597.
26. Jochems SP, Jacquelin B, Chauveau L, et al. Plasmacytoid dendritic cell infection and sensing capacity during pathogenic and nonpathogenic simian immunodeficiency virus infection. J Virol 2015; 89: 6918-6927.
27. Li B, Stefano-Cole K, Kuhrt DM, et al. Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies. J Virol 2010; 84: 6248-6253.
28. Lozano Reina JM, Favre D, Kasakow Z, et al. Gag p27-specific B- and T-cell responses in Simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol 2009; 83: 2770-2777.
29. Liovat AS, Rey-Cuille MA, Lecuroux C, et al. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection. PLoS ONE 2012; 7: e46143.
30. Klatt NR, Bosinger SE, Peck M, et al. Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals. PLoS Pathog 2014; 10: e1004345.
31. Roberts L, Passmore JA, Williamson C, et al. Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. Aids 2010; 24: 819-831.
32. Hatziioannou T, Del Prete GQ, Keele BF, et al. HIV-1-induced AIDS in monkeys. Science 2014; 344: 1401-1405.
33. Bourry O, Mannioui A, Sellier P, et al. Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion. Retrovirology 2010; 7: 78.
34. Brenchley JM, Paiardini M, Knox KS, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008; 112: 2826-2835.
35. Pandrea I, Gaufin T, Brenchley JM, et al. Cutting edge: experimentally induced immune activation in natural hosts of simian immunodeficiency virus induces significant increases in viral replication and CD4+ T cell depletion. J Immunol 2008; 181: 6687-6691.
36. Hao XP, Lucero CM, Turkbey B, et al. Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection. Nat Commun 2015; 6: 8020.
37. Cecchinato V, Trindade CJ, Laurence A, et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol 2008; 1: 279-288.
38. Marchetti G, Tincati C, Silvestri G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev 2013; 26: 2-18.
39. J. Ananworanich, Rv254/Search, and R.S.S. Groups. Schuetz A, Deleage C, Sereti I, et al. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog 2014; 10: e1004543.
40. Ortiz AM, Klase ZA, DiNapoli SR, et al. IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques. Mucosal Immunol 2015.
41. Beaumier CM, Harris LD, Goldstein S, et al. CD4 downregulation by memory CD4+ T cells in vivo renders African green monkeys resistant to progressive SIVagm infection. Nat Med 2009; 15: 879-885.
42. Murayama Y, Amano A, Mukai R, et al. CD4 and CD8 expressions in African green monkey helper T lymphocytes: implication for resistance to SIV infection. Int Immunol 1997; 9: 843-851.
43. Cartwright EK, McGary CS, Cervasi B, et al. Divergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections. J Immunol 2014; 192: 4666-4673.
44. Paiardini M, Cervasi B, Reyes-Aviles E, et al. Low levels of SIV infection in sooty mangabey central memory CD (4)(+) T cells are associated with limited CCR5 expression. Nat Med 2011; 17: 830-836.
45. McGary CS, Cervasi B, Chahroudi A, et al. Increased stability and limited proliferation of CD4+ central memory T cells differentiate nonprogressive simian immunodeficiency virus (SIV) infection of sooty mangabeys from progressive SIV infection of rhesus macaques. J Virol 2014; 88: 4533-4542.
46. Descours B, Avettand-Fenoel V, Blanc C, et al. Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. Clin Infect Dis 2012; 54: 1495-1503.
47. Saez-Cirion A, Bacchus C, Hocqueloux L, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog 2013; 9: e1003211.
48. Mir KD, Mavigner M, Wang C, et al. Reduced simian immunodeficiency virus replication in macrophages of sooty mangabeys is associated with increased expression of host restriction factors. J Virol 2015; 89: 10136-10144.
49. Durudas A, Chen HL, Gasper MA, et al. Differential innate immune responses to low or high dose oral SIV challenge in rhesus macaques. Current HIV research 2011; 9: 276-288.
50. Durudas A, Milush JM, Chen HL, et al. Elevated levels of innate immune modulators in lymph nodes and blood are associated with more-rapid disease progression in simian immunodeficiency virus-infected monkeys. J Virol 2009; 83: 12229-12240.
51. Fallert BA, Poveda S, Schaefer TM, et al. Virologic and immunologic events in hilar lymph nodes during simian immunodeficiency virus infection: development of polarized inflammation. J Acquir Immune Defic Syndr 2008; 47: 16-26.
52. Sarkar S, Kalia V, Murphey-Corb M, et al. Expression of IFN-gamma induced CXCR3 agonist chemokines and compartmentalization of CXCR3+ cells in the periphery and lymph nodes of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome. J Med Primatol 2003; 32: 247-264.
53. Sedaghat AR, German J, Teslovich TM, et al. Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon- mediated disruption of T-cell dynamics. J Virol 2008; 82: 1870-1883.
54. Vanderford TH, Slichter C, Rogers KA, et al. Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation. Blood 2012; 119: 5750-5757.
55. Sandler NG, Bosinger SE, Estes JD, et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 2014; 511: 601-605.
56. Lederer S, Favre D, Walters KA, et al. Transcriptional profiling in pathogenic and nonpathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization. PLoS Pathog 2009; 5: e1000296.
57. Jacquelin B, Mayau V, Targat B, et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009; 119: 3544-3555.
58. Handley SA, Thackray LB, Zhao G, et al. Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome. Cell 2012; 151: 253-266.
59. Casrouge A, Decalf J, Ahloulay M, et al. Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest 2011; 121: 308-317.
60. Qin S, Fallert Junecko BA, Trichel AM, et al. Simian immunodeficiency virus infection alters chemokine networks in lung tissues of cynomolgus macaques: association with Pneumocystis carinii infection. Am J Pathol 2010; 177: 1274-1285.
61. Qin S, Junecko BA, Lucero CM, et al. Simian immunodeficiency virus infection potently modulates chemokine networks and immune environments in hilar lymph nodes of cynomolgus macaques. J Acquir Immune Defic Syndr 2013; 63: 428-437.
62. Iyer SS, Gangadhara S, Victor B, et al. Codelivery of envelope protein in alum with MVA vaccine induces CXCR3-biased CXCR5+and CXCR5- CD4 T cell responses in rhesus macaques. J Immunol 2015; 195: 994-1005.
63. Cameron PU, Saleh S, Sallmann G, et al. Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton. Proc Natl Acad Sci U S A 2010; 107: 16934-16939.
64. Brenchley JM, Vinton C, Tabb B, et al. Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections. Blood 2012; 120: 4172-4181.
65. Beer B, Scherer J, Megede JZ, et al. Lack of dichotomy between virus load of peripheral blood and lymph nodes during long-term simian immunodeficiency virus infection of African green monkeys. Virology 1996; 219: 367.
66. Chakrabarti L, Cumont MC, Montagnier L, Hurtrel B. Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression. J Virol 1994; 68: 6634-6643.
67. Cumont MC, Diop O, Vaslin B, et al. Early divergence in lymphoid tissue apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. J Virol 2008; 82: 1175-1184.
68. Estes JD, Gordon SN, Zeng M, et al. Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques. J Immunol 2008; 180: 6798-6807.
69. Goldstein S, Ourmanov I, Brown CR, et al. Plateau levels of viremia correlate with the degree of CD4+-T-cell loss in simian immunodeficiency virus SIVagm-infected pigtailed macaques: variable pathogenicity of natural SIVagm isolates. J Virol 2005; 79: 5153-5162.
70. Martinot AJ, Meythaler M, Pozzi LA, et al. Acute SIV infection in sooty mangabey monkeys is characterized by rapid virus clearance from lymph nodes and absence of productive infection in germinal centers. PLoS One 2013; 8: e57785.
71. MeythalerM, Wang Z, Martinot A, et al. Early induction of polyfunctional simian immunodeficiency virus (SIV)-specific T lymphocytes and rapid disappearance of SIV from lymph nodes of sooty mangabeys during primary infection. J Immunol 2011; 186: 5151-5161.
72. Beer B, Scherer J, zur Megede J, et al. Lack of dichotomy between virus load of peripheral blood and lymph nodes during long-term simian immunodeficiency virus infection of African green monkeys. Virology 1996; 219: 367-375.
73. Onanga R, Kornfeld C, Pandrea I, et al. High levels of viral replication contrast with only transient changes in CD4+ and CD8+ cell numbers during the early phase of experimental infection with SIVmnd-1 in Mandrillus sphinx. J Virol 2002; 76: 10256-10263.
74. Estes JD, Wietgrefe S, Schacker T, et al. Simian immunodeficiency virusinduced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection. J Infect Dis 2007; 195: 551-561.
75. Estes JD. Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues. Immunol Rev 2013; 254: 65-77.
76. Zeng M, Southern PJ, Reilly CS, et al. Lymphoid tissue damage in HIV-1 infection depletes naive T cells and limits T cell reconstitution after antiretroviral therapy. PLoS Pathog 2012; 8: e1002437.
77. Fletcher CV, Staskus K, Wietgrefe SW, et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A 2014; 111: 2307-2312.
78. Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 2015; 373: 795-807.
79. Passaes CP, Saez-Cirion A. HIV cure research: advances and prospects. Virology 2014; 454-455: 340-352.